Liver transplantation in patients with hepatic iron overload: Favorable or unfavorable outcome?

Hepatology

Volumn 32, Issue 6, 2000, Pages 1396-1398

  Keeffe, Emmet B ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CLINICAL FEATURE; DISEASE SEVERITY; EARLY DIAGNOSIS; EDITORIAL; GENETIC DISORDER; HEMOCHROMATOSIS; HUMAN; IRON OVERLOAD; LIVER CELL; LIVER TRANSPLANTATION; MISSENSE MUTATION; PRIORITY JOURNAL; PROGNOSIS; SEQUENCE ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 0033661474     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2000.20674     Document Type: Article

References (21)

1. Molecular medicine and hemochromatosis: At the crossroads
2. Diagnosis of hemochromatosis
3. End-stage liver disease without hemochromatosis associated with elevated hepatic iron index
4. Hereditary hemochromatosis in liver transplantation
5. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
6. Putting a hold on 'HLA-H.' The WHO Nomenclature Committee for Factors of the HLA System
7. Survival and causes of death in cirrhotic and non-cirrhotic patients with primary hemochromatosis
8. Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis
9. A reappraisal of hepatic siderosis in patients with end-stage cirrhosis: Practical implications for the diagnosis of hemochromatosis
10. Hemosiderosis in cirrhosis: A study of 447 native livers
11. Iron overload in cirrhosis-HFE genotypes and outcome after liver transplantation
12. Prevalence of the C282Y mutation of the hemochromatosis gene in liver transplant recipients and donors
13. Prevalence of hepatic iron overload and HFE mutations among orthotopic liver transplant recipients: Preliminary results from the National Hemochromatosis Transplant Registry
14. An analysis of liver transplant experience from 37 transplant centers as reported to Medicare
15. Liver transplantation for hereditary hemochromatosis (HHC)
16. Outcome of liver transplantation in patients with hemochromatosis
17. Orthotopic liver transplantation for hemochromatosis
18. Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis
19. Long-term follow-up after liver transplantation in patients with hepatic iron overload
20. Survival after orthotopic liver transplantation among patients with hepatic iron overload: Preliminary results from the National Hemochromatosis Transplant Registry
21. Increased hepatic iron and cirrhosis: No evidence for an adverse effect on patient outcome following liver transplantation